-
EP3833692
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3833692
| EP3833692 - ANTI-FACTOR XI ANTIBODIES [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 20.08.2021 Database last updated on 09.04.2026 | |
| Former | Request for examination was made Status updated on 14.05.2021 | ||
| Former | The international publication has been made Status updated on 15.02.2020 | Most recent event Tooltip | 20.08.2021 | Withdrawal of application | published on 22.09.2021 [2021/38] | Applicant(s) | For all designated states Shanghai Benemae Pharmaceutical Corporation No. 916 Ziping Rd. Zhoupu Town Pudong New Area Shanghai 201321 / CN | [2021/24] | Inventor(s) | 01 /
WANG, Wenyi No. 916 Ziping Road Zhoupu Town Pudong New Area Shanghai 201321 / CN | 02 /
YU, Quan No. 916 Ziping Road Zhoupu Town Pudong New Area Shanghai 201321 / CN | 03 /
LIU, Xiaowu No. 916 Ziping Road Zhoupu Town Pudong New Area Shanghai 201321 / CN | 04 /
XU, John Liuzhong No. 916 Ziping Road Zhoupu Town Pudong New Area Shanghai 201321 / CN | 05 /
DU, Zhiqiang No. 916 Ziping Road Zhoupu Town Pudong New Area Shanghai 201321 / CN | [2021/24] | Representative(s) | Gulde & Partner Patent- und Rechtsanwaltskanzlei mbB Berliner Freiheit 2 10785 Berlin / DE | [N/P] |
| Former [2021/24] | Gulde & Partner Patent- und Rechtsanwaltskanzlei mbB Wallstraße 58/59 10179 Berlin / DE | Application number, filing date | 18929685.8 | 09.08.2018 | [2021/24] | WO2018CN99638 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020029179 | Date: | 13.02.2020 | Language: | EN | [2020/07] | Type: | A1 Application with search report | No.: | EP3833692 | Date: | 16.06.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.02.2020 takes the place of the publication of the European patent application. | [2021/24] | Search report(s) | International search report - published on: | CN | 13.02.2020 | Classification | IPC: | C07K16/36, C12N15/13, C12N15/63, A61K39/395, A61P7/02 | [2021/24] | CPC: |
A61P7/02 (EP,CN,KR);
C07K16/36 (EP,CN,KR);
A61P7/00 (CN);
C12N15/85 (CN);
A61K2039/505 (EP,CN,KR);
C07K2317/24 (EP,KR);
C07K2317/33 (EP,KR);
C07K2317/565 (EP,CN,KR);
C07K2317/76 (EP,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/24] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | ANTI-FAKTOR-XI-ANTIKÖRPER | [2021/24] | English: | ANTI-FACTOR XI ANTIBODIES | [2021/24] | French: | ANTICORPS ANTI-FACTEUR XI | [2021/24] | Entry into regional phase | 20.01.2021 | National basic fee paid | 20.01.2021 | Search fee paid | 20.01.2021 | Designation fee(s) paid | 20.01.2021 | Examination fee paid | Examination procedure | 20.01.2021 | Examination requested [2021/24] | 12.08.2021 | Application withdrawn by applicant [2021/38] | Fees paid | Renewal fee | 20.01.2021 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A] WO2009067660 (UNIV OREGON HEALTH & SCIENCE et al.) [A] 1-5, 12-17(part) * See the whole document * | [A] WO2017162791 (PROTHIX BV et al.) [A] 1-5, 12-17(part) * See the whole document * | [E] WO2018145533 (SHANGHAI BENEMAE PHARMACEUTICAL CORP et al.) [E] 1-5, 12-17(part) * See description, paragraph 0004-0010, 0025-0047, claims and SEQ ID N0S:9-10 * |